Sigyn Therapeutics SIGY
OTC SIGY
$0.03 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Sigyn Therapeutics (SIGY) Divestments (2019)

Sigyn Therapeutics (SIGY) posted Divestments of $100000.0 for Q1 2019.

Sigyn Therapeutics (SIGY) Divestments (2019) Analysis & Trends

Sigyn Therapeutics has reported Divestments for 1 years, with the latest figure at $100000.0 in Q1 2019.

  • Quarterly Divestments changed N/A year-over-year to $100000.0 in Q1 2019, while the trailing twelve-month figure through Dec 2019 was $100000.0 (changed N/A YoY) and the FY2019 annual result came in at $100000.0, changed N/A from the prior year.
  • Divestments held at $100000.0 in Q1 2019 per SIGY's latest filing.
  • Over five years, Divestments peaked at $100000.0 in Q1 2019 and troughed at $100000.0 in Q1 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn -
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn -
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn -
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn -
8 Royalty Pharma 26.98 Bn 26.14 Bn - -13.21 Mn
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -
10 Sigyn Therapeutics 48,161.31 -37,409.69 - -

Historic Data

Download Data
DateValue
Mar 31, 2019 100,000.00